Literature DB >> 7022769

The interaction of spironolactone and digoxin: a review and evaluation.

R W Thomas, R R Maddox.   

Abstract

A review of the literature describing the interaction of digoxin and spironolactone is presented. Two mechanisms of possible interaction are discussed. Spironolactone and its metabolites may interfere with digoxin radioimmunoassay or alter the pharmacokinetics of digoxin. The occurrence of either or both of these processes may make interpretation of serum digoxin levels difficult.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7022769     DOI: 10.1097/00007691-198102000-00001

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  4 in total

1.  Increase of plasma digoxin levels after withdrawal from therapy in an elderly patient.

Authors:  Z Duraković
Journal:  Cardiovasc Drugs Ther       Date:  1995-12       Impact factor: 3.727

2.  Digoxin-interactions in man: spironolactone reduces renal but not biliary digoxin clearance.

Authors:  A Hedman; B Angelin; A Arvidsson; R Dahlqvist
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  The effect of renal and hepatic impairment and of spironolactone on digoxin immunoassays.

Authors:  R G Morris; D B Frewin; W B Taylor; M L Glistak; D R Lehmann
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  Association between the number of coadministered P-glycoprotein inhibitors and serum digoxin levels in patients on therapeutic drug monitoring.

Authors:  Gunilla Englund; Pär Hallberg; Per Artursson; Karl Michaëlsson; Håkan Melhus
Journal:  BMC Med       Date:  2004-04-02       Impact factor: 8.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.